Dermatology News and Research

Latest Dermatology News and Research

Scientists identify a new approach to treating sarcoidosis

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis.

23 Jan 2024

Immune checkpoint inhibitor target found to promote skin cancer growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

19 Jan 2024

Missing proteins explain century-old mystery of scalp skin absence in children

Children with the condition aplasia cutis congenita (ACC) are born with the absence of skin along the midline of the scalp.

3 Jan 2024

Unraveling nuanced roles of JAK inhibitors in inflammation

Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues.

21 Dec 2023

$Higher doses of topical corticosteroids linked to increased risks of osteoporosis and bone fractures$

Higher doses of topical corticosteroids linked to increased risks of osteoporosis and bone fractures

New research indicates that higher doses of topical corticosteroids, which are commonly used to treat inflammatory skin conditions, are linked with elevated risks of osteoporosis and bone fractures associated with osteoporosis.

20 Dec 2023

Study exposes racial disparities in Lyme disease diagnosis and treatment times

Study reveals racial disparities in Lyme disease diagnosis and treatment, with Black patients experiencing longer delays and higher risks of disseminated disease compared to White patients.

14 Dec 2023

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.

From SolasCure 12 Dec 2023

Large language models enhance differential diagnosis, paving the way for AI-assisted medical decision-making

Study explores optimizing large language models (LLMs) for differential diagnosis (DDx), demonstrating their potential in assisting clinicians with accurate disease diagnosis using real-world medical cases.

7 Dec 2023

Study exposes societal stigma and misconceptions about acne

Study reveals societal stigma and negative stereotypes associated with acne, highlighting the need for greater awareness and understanding of this skin condition.

7 Dec 2023

Individuals with acne face stigmatizing attitudes from the general public, study finds

A new study highlights how stigmatizing attitudes about individuals with acne may influence social and professional perceptions.

6 Dec 2023

FTC chief gears up for a showdown with private equity

A recent Federal Trade Commission civil lawsuit accusing one of the nation's largest anesthesiology groups of monopolistic practices that sharply drove up prices is a warning to private equity investors that could temper their big push to snap up physician groups.

30 Nov 2023

Heat shock protein protects bacteria from plasma treatment

A heat shock protein protects the cells against protein clumping. It degrades, however, over longer treatment periods.

24 Nov 2023

Researchers discover new option to target the metastatic capacity of melanoma cells

As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in the fight against deadly metastasis, but existing therapeutic measures are still not effective in many cases.

21 Nov 2023

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation.

20 Nov 2023

Compensation is key to fixing primary care shortage

Money talks. The United States faces a serious shortage of primary care physicians for many reasons, but one, in particular, is inescapable: compensation.

16 Nov 2023

Allen Discovery Center for Neuroimmune Interactions launched at Mount Sinai

The Paul G. Allen Frontiers Group, a division of the Allen Institute, today announced the launch of the Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai.

9 Nov 2023

New pathologic scoring system could help predict survival in lung cancer patients

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

6 Nov 2023